BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31616249)

  • 1. Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells.
    Baaklini CS; Rawji KS; Duncan GJ; Ho MFS; Plemel JR
    Front Mol Neurosci; 2019; 12():225. PubMed ID: 31616249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Astrocytes in Remyelination.
    Rawji KS; Gonzalez Martinez GA; Sharma A; Franklin RJM
    Trends Neurosci; 2020 Aug; 43(8):596-607. PubMed ID: 32620289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
    Alizadeh A; Karimi-Abdolrezaee S
    J Physiol; 2016 Jul; 594(13):3539-52. PubMed ID: 26857216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative Capacity of Macrophages for Remyelination.
    Rawji KS; Mishra MK; Yong VW
    Front Cell Dev Biol; 2016; 4():47. PubMed ID: 27243011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
    Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
    Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Csf1 Deficiency Dysregulates Glial Responses to Demyelination and Disturbs CNS White Matter Remyelination.
    Wylot B; Mieczkowski J; Niedziolka S; Kaminska B; Zawadzka M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31906095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
    Skaper SD
    Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
    Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
    Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of Caloric Restriction Mimetics in Central Nervous System Demyelination and Remyelination.
    Kaffe D; Kaplanis SI; Karagogeos D
    Curr Issues Mol Biol; 2023 Nov; 45(12):9526-9548. PubMed ID: 38132442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
    Duncan GJ; Manesh SB; Hilton BJ; Assinck P; Plemel JR; Tetzlaff W
    Glia; 2020 Feb; 68(2):227-245. PubMed ID: 31433109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies.
    Dulamea AO
    Neural Regen Res; 2017 Dec; 12(12):1939-1944. PubMed ID: 29323026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
    Psachoulia K; Chamberlain KA; Heo D; Davis SE; Paskus JD; Nanescu SE; Dupree JL; Wynn TA; Huang JK
    Brain; 2016 Dec; 139(Pt 12):3121-3136. PubMed ID: 27797811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes in myelination and remyelination.
    Molina-Gonzalez I; Miron VE
    Neurosci Lett; 2019 Nov; 713():134532. PubMed ID: 31589903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.